Woodline Partners’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107M | Sell |
|
|||||
|
2025
Q1 | $137M | Buy |
|
|||||
|
2024
Q4 | $170M | Buy |
|
|||||
|
2024
Q3 | $156M | Buy |
|
|||||
|
2024
Q2 | $128M | Sell |
|
|||||
|
2024
Q1 | $122M | Buy |
|
|||||
|
2023
Q4 | $84.9M | Sell |
|
|||||
|
2023
Q3 | $87.1M | Sell |
|
|||||
|
2023
Q2 | $101M | Buy |
|
|||||
|
2023
Q1 | $74.1M | Buy |
|
|||||
|
2022
Q4 | $10.7M | Sell |
|
|||||
|
2022
Q3 | $11.1M | Buy |
|
|||||
|
2022
Q2 | $5.14M | Sell |
|
|||||
|
2022
Q1 | $59.5M | Sell |
|
|||||
|
2021
Q4 | $73.7M | Buy |
|
|||||
|
2021
Q3 | $23.9M | Buy |
|
|||||
|
2021
Q2 | $27M | Buy |
|
|||||
|
2021
Q1 | $38.6M | Buy |
|
|||||
|
2020
Q4 | $32M | Buy |
|
|||||
|
2020
Q3 | $971K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.2M | Buy |
|